Table 1.
Baseline characteristics
| |
Patients with exacerbation |
Stable patients |
p-value |
|---|---|---|---|
| (n = 19) | (n = 10) | ||
| Age (yrs) |
25 ± 6 |
29 ± 8 |
0.14 |
| Gender (male/female) |
13/6 |
6/4 |
0.70 |
| BMI (kg/m2) |
20.9 ± 2.9 |
20.4 ± 2.0 |
0.63 |
| Chronic PA colonization (n) |
14 (74%) |
10 (100%) |
0.07 |
| CF-related diabetes mellitus (n) |
11 (58%) |
2 (20%) |
0.051 |
| Pancreas insufficiency (n) |
16 (84%) |
9 (90%) |
0.67 |
| Genotype ΔF508/ΔF508 (n) |
12 (63%) |
5 (50%) |
0.49 |
| # Exacerbations in 12 months prior to inclusion | 1 [0–2] | 0 [0–1] | 0.09 |
Data are presented as mean ± standard deviation or median [interquartile range]. BMI = body mass index, PA = Pseudomonas Aeruginosa, CF = cystic fibrosis.